Genextra S.p.A. 13D and 13G filings for Intercept Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-02 4:58 pm Sale | 2022-09-02 | 13G | INTERCEPT PHARMACEUTICALS INC ICPT | Genextra S.p.A. | 4,000,000 13.400% | -31,994 (-0.79%) | Filing |